The ONCO-REVEAL Lung and Colon Cancer Hotspot Panel is a focused assay targeting key relevant regions for detection and related to regions associated with targeted therapies for these cancers. 1800 hotspots across 22 genes that require only 2.5ng of input. Targets are based on data across consortiums and groups such as CAP, AMP, NCCN, the COSMIC database as well as clinical trials among others.
- Compatible with genomic DNA, FFPE and ctDNA
- Single pool workflow for enhanced sensitivity
- Coverage uniformity 100% within .15x of the mean
- Detect down to 1% allele frequency